What is MitraClip?
The MitraClip is an FDA-approved device used to treat severe mitral regurgitation. This condition occurs when the heart’s mitral valve does not close completely, allowing blood to leak backward into the heart.
During a minimally invasive procedure, the MitraClip is guided through the femoral vein to the heart’s left atrium. There, the clip attaches to the leaflets of the mitral valve, where it tightens the valve’s seal. The blood flow on both sides of the clip is then regulated while reducing regurgitation into the heart.
Who qualifies for the device?
The MitraClip procedure is ideal for patients suffering from valve-related congestive heart failure and is not responding to medical treatment. Patients who are unsuitable for surgical options would also benefit from the MitraClip procedure. Other notable benefits of the MitraClip include:
- Patients who receive the MitraClip experience a quicker recovery, with less pain and discomfort, than patients who receive surgical treatment.
- Patients can resume normal activities within 24-48 hours following the procedure.
Your doctor may recommend a MitraClip if you are experiencing symptoms that suggest mitral regurgitation, including:
- Fatigue or inability to exercise
- Decrease in appetite
- Dry cough that is often worse when lying down
- Shortness of breath
- Accumulation of fluid in the feet, ankles, or lungs